Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP) (THALA-RAP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04247750 |
|
Recruitment Status :
Recruiting
First Posted : January 30, 2020
Last Update Posted : November 12, 2021
|
Sponsor:
Università degli Studi di Ferrara
Collaborators:
Rare Partners srl Impresa Sociale
Azienda Ospedaliero, Universitaria Meyer
Azienda Ospedaliero, Universitaria Pisana
Information provided by (Responsible Party):
Maria Rita Gamberini, Azienda USL Ferrara
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 30, 2022 |
| Estimated Study Completion Date : | April 30, 2022 |